Safety and well-being in your organization is important

 

Thermo Fisher Scientific is enabling enterprise organizations to safely navigate through the pandemic in partnership with Everlywell. Together we can help you navigate the testing landscape to ensure a safe workplace or academic environment and peace of mind for your employees and their families.

COVID-19 diagnostic testing is a valuable component of safety protocols

Program Objectives

  • Learn about the difference between diagnostic and antibody testing
  • Gain understanding of different testing modalities to understand what would work best for your organization
  • Discuss the value and rationale for implementing testing in the workplace
  • Hear about Thermo Fisher and Everlywell’s end-to-end testing solution

Safety and well-being in the workplace

Program Objectives

  • Discuss the value and rationale for implementing COVID-19 testing in the workplace
  • Hear real-world strategies on workplace testing and policies
  • Gain understanding of Everlywell turn-key resources for sample collection, test reporting and result-related actions
  • Share insights on best practices for communicating and implementing a testing program

COVID-19 diagnostic testing is a valuable component of safety protocols

Program Objectives

  • Learn about the difference between diagnostic and antibody testing
  • Gain understanding of different testing modalities to understand what would work best for your organization
  • Discuss the value and rationale for implementing testing in the workplace
  • Hear about Thermo Fisher and Everlywell’s end-to-end testing solution

Safety and well-being in the workplace

Program Objectives

  • Discuss the value and rationale for implementing COVID-19 testing in the workplace
  • Hear real-world strategies on workplace testing and policies
  • Gain understanding of Everlywell turn-key resources for sample collection, test reporting and result-related actions
  • Share insights on best practices for communicating and implementing a testing program

 

Learn more about COVID-19 workplace testing with Everlywell
Everlywell offers an end-to-end service solution to access diagnostic testing leveraging Thermo Fisher Scientific's trusted technology:
  • Easy-to-use sample collection
  • Telehealth consultations with board-certified physicians for those with positive results
  • Flexibility to send collection kits across the U.S. to home or work 
  • Online results on HIPPA-compliant digital platform
  • Thermo Fisher’s FDA-authorized molecular qPCR test
  • Digital reporting back to the organization as well as appropriate local and federal agencies

Find out more

PG2125-PJT6081-COL112035-COVID-Employer-Webinar-Flyer-NA-Americas-D4

 

 

Thermo Fisher Scientific's COVID-19
global response

We remain dedicated to the global fight against SARS-CoV-2

We are here to support researchers and scientists across the globe who are working to develop treatments and vaccines for COVID-19. Now, more than ever, we remain steadfast in our mission to make the world healthier, cleaner, and safer.

Trust that our team of experts is here to address your individual product needs and offer remote support for your SARS-CoV-2 research  

With an ability to conduct remote instrument support and quickly scale development and production, Thermo Fisher Scientific provides the products and support needed to keep your lab running even in areas where travel is restricted.

View COVID-19 FAQs, news, and resources from Thermo Fisher Scientific ›

 


Neither the TaqPath COVID-19 Combo Kit, nor the Everlywell COVID-19 Test Home Collection Kit are FDA cleared, but both are permitted for Emergency Use Authorization (EUA) only. The Everlywell kit is authorized only for the home collection of nasal swab specimens to aid in detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. EUA amendment for use of TaqPath COVID-19 Combo Kit with Everlywell COVID-19 Test Home Collection Kit under development (“Proposed Amended EUA”). Proposed Amended EUA is not cleared for use nor commercially available. Any EUA product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.
Style Sheet for Komodo Tabs
Style Sheet for Global Design System